The following post was posted by "Watsonhelper" on
Post# of 30027
Posted On: 06/20/2015 9:29:43 AM
The following post was posted by "Watsonhelper" on the AMBS Yahoo Board yesterday. I think there is some validity to his speculation regarding Fidelity and Becton Dickinson.
Two key things happened this week
Fidelity bioscience started accumulating, they generally take 2-6%, you'll see filing if they cross 5%. I do know a key VP at Fidelity and they are targeting the guidance at $26 by end of summer. They accumulate over a period of 1-2 weeks on average based on history. Secondarily, word is very strong that Lympro comes through with a BD deal next week, people may be buying on this as it's very prominent. You are going to ask my source, this one is easy, BD. They have been nervous about a bkrpt position LY and apparently that is why they pulled out. Dominion has agreed to fund the next two years of operations, so they are placing up numbers per the word on the street. Do you own DD as always, not looking for trust, can care less if you believe me, I also look forward to WatsonHEPler commenting. I know there's still a lot of good people here despite the anger and frustration, I have a feeling with all of these key things happening around the uplist and analyst coverage starting in two weeks, things will change for the better very fast. Whether you like Gerald or not, the science will carry them. He's not blogging as I am sure the exchange is telling him to shut up right now until they clear this hurdle.
Two key things happened this week
Fidelity bioscience started accumulating, they generally take 2-6%, you'll see filing if they cross 5%. I do know a key VP at Fidelity and they are targeting the guidance at $26 by end of summer. They accumulate over a period of 1-2 weeks on average based on history. Secondarily, word is very strong that Lympro comes through with a BD deal next week, people may be buying on this as it's very prominent. You are going to ask my source, this one is easy, BD. They have been nervous about a bkrpt position LY and apparently that is why they pulled out. Dominion has agreed to fund the next two years of operations, so they are placing up numbers per the word on the street. Do you own DD as always, not looking for trust, can care less if you believe me, I also look forward to WatsonHEPler commenting. I know there's still a lot of good people here despite the anger and frustration, I have a feeling with all of these key things happening around the uplist and analyst coverage starting in two weeks, things will change for the better very fast. Whether you like Gerald or not, the science will carry them. He's not blogging as I am sure the exchange is telling him to shut up right now until they clear this hurdle.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼